Trial Profile
Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage Alzheimer's Disease Having Coexisting Small Vessel Cerebrovascular Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2021
Price :
$35
*
At a glance
- Drugs Rivastigmine (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- 03 Mar 2021 Status changed from recruiting to completed.
- 18 May 2015 New trial record